Jon Smith, reporter at BioXconomy, has published a deep article about the industry’s forecast and perspectives for 2025 featuring Ali Pashazadeh, Treehill Partners CEO, along other industry leaders.
“It is understandable to be cautious as biopharma endures a perfect storm of shifting governments, new leaders and a tough investment market. On the other hand … we could all be nervous and cautious, or we could think about change and embrace it” comments Pashazadeh.
BioXconomy, an Informa Connect Life Sciences title, is a new publication filling the gap in corporate, business, financial and investment life science reporting.
Read the full article on BioXconomy:
https://www.bioxconomy.com/investment/takeovers-trump-and-trends-how-biopharma-is-shifting-this-year